Suboxone During Pregnancy: Is It Safe for You & Baby?

Finding out you're pregnant while taking Suboxone — or discovering you need treatment while already expecting — brings a flood of questions and fears. You want what's best for your baby, and the last thing you want is to cause harm. The guilt can feel crushing.
Here's what matters most: staying on buprenorphine during pregnancy is medically recommended and significantly safer than stopping treatment or continuing untreated opioid use. Decades of research support this. Withdrawal during pregnancy carries serious risks for both you and your baby, while managed medication-assisted treatment protects you both.
This guide walks through the science behind buprenorphine use during pregnancy, what to expect throughout your pregnancy and after delivery, and how to access coordinated care that supports both your recovery and your baby's health.
Why Continuing Treatment During Pregnancy Is Critical
When you're pregnant and have opioid use disorder, stopping medication abruptly isn't just difficult — it's dangerous. Opioid withdrawal causes intense physical stress that can trigger miscarriage, preterm labor, or fetal distress. The relapse risk is also extremely high, and returning to opioid use during pregnancy carries far greater risks than staying on medication.
Untreated opioid use disorder during pregnancy is associated with:
- Poor prenatal care — unpredictable drug use makes it harder to attend appointments consistently
- Higher infection rates — particularly with injection drug use
- Placental complications — including placental abruption
- Preterm birth and low birth weight
- Stillbirth and neonatal death
- Sudden withdrawal in utero — which can be life-threatening to the fetus
Medication-assisted treatment eliminates these chaotic cycles. When you're stable on buprenorphine, you can focus on prenatal care, nutrition, and preparing for your baby's arrival. You're not cycling between intoxication and withdrawal, and your baby receives consistent oxygen and nutrients.
The medical consensus is clear: buprenorphine treatment during pregnancy saves lives — both yours and your baby's.
What the Research Shows: The MOTHER Trial
The landmark study guiding modern prenatal buprenorphine care is called the MOTHER trial (Maternal Opioid Treatment: Human Experimental Research), published in 2010. This randomized controlled trial directly compared buprenorphine to methadone in pregnant women with opioid use disorder.
The findings were striking:
- Both medications were safe for pregnancy and significantly better than no treatment
- Babies whose mothers took buprenorphine required less medication for neonatal abstinence syndrome (NAS) and had shorter hospital stays
- Maternal outcomes were excellent in both groups when combined with prenatal care
- No increased birth defects were found with either medication
Multiple follow-up studies have confirmed these results. Buprenorphine is now considered a first-line treatment option for pregnant people with opioid use disorder by the American College of Obstetricians and Gynecologists (ACOG), the American Society of Addiction Medicine (ASAM), and the World Health Organization (WHO).
If you're already stable on buprenorphine when you become pregnant, continuing your medication is almost always the recommended path. If you're not yet in treatment, starting buprenorphine during pregnancy is safe and strongly encouraged.
Suboxone vs. Subutex: The Naloxone Question
You may have heard that pregnant women should switch from Suboxone (buprenorphine/naloxone) to Subutex (buprenorphine-only). This recommendation comes from an abundance of caution, not evidence of harm.
Here's the nuance: Naloxone — the second ingredient in Suboxone that blocks opioid receptors — is poorly absorbed when taken as directed under the tongue. It's designed to prevent misuse (if someone tries to inject Suboxone, the naloxone activates and causes immediate withdrawal). During normal sublingual use, very little naloxone enters your bloodstream, and even less crosses the placenta.
That said, most OB-GYNs and addiction specialists prefer buprenorphine-only formulations during pregnancy simply because we have more long-term safety data on them. Some insurance plans also have policies requiring the switch.
If your provider recommends switching from Suboxone to Subutex:
- The transition is straightforward — same dose, just without the naloxone component
- You shouldn't feel different — buprenorphine is the active medication doing the work
- It's a precautionary measure, not an emergency — if Subutex isn't available immediately, continuing Suboxone is far safer than going without
Never stop your medication while waiting for a prescription change. Grata Health providers can coordinate these transitions smoothly and work with your OB-GYN to ensure continuity of care. See how online Suboxone treatment works if you need to establish care quickly.
What Is Neonatal Abstinence Syndrome (NAS)?
Neonatal abstinence syndrome, or NAS, is a constellation of symptoms that some babies experience after birth when they're no longer receiving buprenorphine through the placenta. It's important to understand what NAS is — and what it isn't.
NAS is not the same as adult opioid withdrawal. Babies don't experience the psychological cravings or distress that adults do. NAS is primarily a physical adjustment, and it's temporary, predictable, and very treatable.
Common NAS symptoms include:
- Irritability and high-pitched crying
- Tremors or jitteriness
- Difficulty sleeping
- Feeding difficulties (fast sucking, poor coordination)
- Loose stools
- Sweating or mild fever
- Sneezing and stuffy nose
Not all babies exposed to buprenorphine develop NAS, and when they do, symptoms are typically milder and shorter-lasting than with other opioids. About 30-60% of babies exposed to buprenorphine will need some level of monitoring or treatment, compared to 70-90% of babies exposed to methadone.
Most hospitals have standardized NAS protocols using a scoring system to assess symptom severity. When treatment is needed, babies usually receive small amounts of morphine or methadone, which are gradually tapered over days or weeks. The vast majority of babies go home healthy with their mothers within a few weeks.
Crucially, NAS does not cause long-term developmental harm. Multiple studies following children exposed to buprenorphine prenatally have found normal developmental outcomes when compared to unexposed children.
Getting coordinated care early in your pregnancy allows your delivery hospital to prepare and gives you time to ask questions about their NAS protocols.
Coordinating Prenatal and Addiction Care
The best outcomes happen when your OB-GYN and addiction medicine provider work together. You deserve seamless, stigma-free care that treats your whole health.
Here's what coordinated care looks like:
From your addiction medicine provider:
- Regular check-ins to monitor medication stability
- Dose adjustments if needed (some people require higher doses in the third trimester)
- Urine drug screening to confirm treatment adherence and screen for other substances
- Mental health support and counseling
- Connection to resources like prenatal vitamins, nutrition assistance, and transportation help
From your OB-GYN:
- Standard prenatal care and ultrasounds
- Monitoring for pregnancy complications
- Planning for delivery and postpartum care
- Communication with the hospital about your treatment plan
- Breastfeeding guidance
At the delivery hospital:
- NAS monitoring protocols for your baby
- Support for rooming-in (keeping baby with you)
- Lactation support if you choose to breastfeed
- Social work services to help with discharge planning
Grata Health specializes in supporting pregnant patients through our telehealth platform, offering flexible appointments that work around your prenatal care schedule. We coordinate directly with OB-GYNs in Virginia, Ohio, and Pennsylvania and can help you find supportive obstetric care if you haven't established it yet.
Most insurance plans, including Medicaid, Aetna, and Blue Cross Blue Shield, cover prenatal buprenorphine treatment. If you're worried about cost, our team can help verify your coverage and connect you with additional resources.
Breastfeeding While Taking Buprenorphine
Another common concern is whether it's safe to breastfeed while taking buprenorphine. The answer is yes, breastfeeding is encouraged if you're stable on your medication and not using other substances.
Only tiny amounts of buprenorphine pass into breast milk — far less than what your baby was exposed to during pregnancy. Studies show that breastfeeding may actually reduce the severity of NAS symptoms and shorten hospital stays for babies who need monitoring.
The benefits of breastfeeding (bonding, immune support, nutrition) far outweigh the minimal medication exposure. The American Academy of Pediatrics supports breastfeeding for mothers on buprenorphine.
You should avoid breastfeeding if:
- You're actively using illicit opioids or other contraindicated substances
- You have untreated HIV or active tuberculosis
- Your provider has specific medical concerns
Otherwise, breastfeed with confidence. It's one more way you're giving your baby the best start.
Managing Stigma and Building Your Support System
Even with all the science supporting your treatment, you may still face judgment — from family, from medical providers who aren't educated in addiction medicine, or from the internalized shame many people carry.
You deserve to know: choosing treatment during pregnancy is an act of courage and love for your child. You're making the medically recommended choice. Any provider who shames you for being on medication is operating from outdated beliefs, not evidence.
Building a support system helps immensely:
- Find a judgment-free OB-GYN — Ask your addiction medicine provider for referrals to OB practices experienced with MAT patients
- Connect with other parents in recovery — Many communities have peer support groups specifically for pregnant and parenting people
- Educate your loved ones — Share resources from ACOG or SAMHSA with family members who don't understand
- Set boundaries — You don't owe anyone an explanation for your medical treatment
- Celebrate milestones — Every prenatal appointment you make, every dose you take consistently, every day you stay stable is a victory
Your Grata Health care team is here to support you through all of it. We've worked with hundreds of pregnant patients and know firsthand how strong you are.
What Happens After Delivery
Your treatment doesn't end when your baby is born — and that's a good thing. Postpartum is a high-risk time for relapse, especially when you're dealing with sleep deprivation, hormonal changes, and the demands of caring for a newborn.
Staying on buprenorphine postpartum is standard and recommended. Most people continue their medication for at least a year after delivery, and many stay on it longer as part of their long-term recovery plan. There's no rush to taper, and when you do decide to taper, it should be slow and supported.
Postpartum priorities include:
- Continuing your buprenorphine appointments — telehealth makes this much easier with a newborn at home
- Watching for postpartum depression — addiction and mental health are closely linked, and new parents in recovery face higher risks
- Building daily routines — creating structure and stability helps you stay grounded
- Asking for help — whether it's childcare, household tasks, or just someone to talk to
- Giving yourself grace — early parenthood is overwhelming for everyone; you're doing it while also maintaining your recovery
Grata Health offers same-day appointments and flexible scheduling specifically to support parents who can't easily leave home. If you're struggling with postpartum mental health, we can coordinate with therapists and psychiatrists who understand the intersection of addiction and perinatal mood disorders.
Getting Started with Prenatal Buprenorphine Care
If you're pregnant and using opioids, or if you're on Suboxone and just found out you're expecting, the most important step is reaching out for coordinated care as soon as possible. Early treatment improves outcomes for both you and your baby.
Grata Health makes it simple to start:
Same-day appointments available — often within hours of reaching out
Insurance accepted — including Ohio Medicaid and most major plans
OB-GYN coordination — we communicate directly with your prenatal care team
No judgment, ever — our providers specialize in addiction medicine and understand pregnancy complexities
You don't have to navigate this alone. Get started today and give yourself and your baby the healthiest path forward.
Frequently Asked Questions About Buprenorphine and Pregnancy
Can I start buprenorphine treatment for the first time during pregnancy?
Yes. Starting treatment during pregnancy is safe and strongly recommended if you have opioid use disorder. The risks of untreated opioid use far exceed any risks from buprenorphine.
Will taking Suboxone cause birth defects?
No. Large studies, including the MOTHER trial, have found no increased risk of birth defects with buprenorphine use during pregnancy compared to the general population.
What if I relapse during pregnancy?
Relapse doesn't mean you've failed. Tell your provider immediately so they can adjust your treatment plan, assess for any medical concerns, and help you get back to stability. Honesty is crucial for your safety and your baby's.
Do I have to tell my OB-GYN I'm on Suboxone?
Yes. Your OB needs this information to provide appropriate prenatal care, coordinate with your addiction medicine provider, and ensure the hospital is prepared for delivery and any NAS monitoring your baby might need.
Can I switch from methadone to buprenorphine during pregnancy?
Sometimes, but it requires careful medical supervision. If you're stable on methadone, most providers recommend staying on it throughout pregnancy. If you're considering a switch, discuss the risks and benefits with your addiction medicine provider and OB-GYN.
What if my family doesn't support me staying on medication?
Educate them using resources from medical organizations like ACOG. If they remain unsupportive, prioritize your and your baby's health. Your medical team and peer support groups can provide the encouragement you need.
You're Making the Right Choice
Pregnancy is already full of anxiety and overwhelming decisions. Adding recovery to the mix can feel impossible. But here's the truth: by seeking information, by staying on or starting buprenorphine treatment, by showing up for prenatal care — you're already doing everything right.
You're not putting your medication before your baby. You're choosing the safest, most evidence-based path available. You're giving your child the gift of a parent who's alive, healthy, and present.
Thousands of people have walked this path before you and gone on to have healthy pregnancies, healthy babies, and thriving families. You can too.
If you're ready to start or continue treatment during pregnancy, Grata Health is here to support you with compassionate, coordinated care. You deserve a healthcare team that sees your strength, not your struggles — and that's exactly what we provide.
About the author
Editorial Team
The Grata Editorial Team produces evidence-based content on opioid use disorder, medication-assisted treatment, and recovery. Our writers work closely with licensed clinicians to ensure every article reflects the latest medical guidance and supports people seeking help for substance use disorders.
View full profileMedically reviewed by
Clinical Review Team
The Grata Care Team is a group of board-certified physicians and addiction medicine specialists who review all clinical content for accuracy. Our clinicians bring decades of combined experience in opioid use disorder treatment, buprenorphine prescribing, and telehealth-based addiction care.
View full profileReady to start your recovery?
Same-day telehealth appointments with licensed providers. Private, affordable, and covered by most insurance.
Get Care

